找回密碼
 To register

QQ登錄

只需一步，快速開(kāi)始

掃一掃，訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Drug Delivery Challenges and Novel Therapeutic Approaches for Retinal Diseases; Christopher L. Cioffi Book 2020 Springer Nature Switzerlan

[復(fù)制鏈接]
查看: 7098|回復(fù): 39
樓主
發(fā)表于 2025-3-21 17:52:28 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書(shū)目名稱Drug Delivery Challenges and Novel Therapeutic Approaches for Retinal Diseases
編輯Christopher L. Cioffi
視頻videohttp://file.papertrans.cn/284/283037/283037.mp4
概述Presents the current state of ocular drug therapy.Reviews the unique challenges faced for ocular drug discovery and delivery.Highlights future therapeutic opportunities for age-related macular degener
叢書(shū)名稱Topics in Medicinal Chemistry
圖書(shū)封面Titlebook: Drug Delivery Challenges and Novel Therapeutic Approaches for Retinal Diseases; Christopher L. Cioffi Book 2020 Springer Nature Switzerlan
描述.This book reviews the current state of ocular drug therapy and future therapeutic opportunities for a wide variety of conditions, including Age-related Macular Degeneration, Diabetic Retinopathy and Macular Edema, Glaucoma, and Inherited Retinal Diseases..Retinal diseases are major contributors to moderate or severe vision impairment in adults aged 50 years and older. The respective patient populations for many of these indications is expected to significantly increase as the world population continues to grow older. An improved understanding of the etiological underpinnings of ocular degenerative diseases over the past decade has significantly bolstered ophthalmic drug discovery..In this volume, contributions from leading experts explore the unique challenges faced for ocular drug discovery and delivery providing the reader with detailed information on ocular pharmacokinetics, .in vitro, ex vivo. and .in vivo. models for retinal disease pathology and emerginggene therapy treatments. The book is intended for all researchers and clinicians who wish to increase their knowledge on the latest findings in ocular drug therapy..
出版日期Book 2020
關(guān)鍵詞Macular Degeneration; Stargardt Disease; Glaucoma; Diabetic Retinopathy; Diabetic Macular Edema; Ocular P
版次1
doihttps://doi.org/10.1007/978-3-030-56619-7
isbn_softcover978-3-030-56621-0
isbn_ebook978-3-030-56619-7Series ISSN 1862-2461 Series E-ISSN 1862-247X
issn_series 1862-2461
copyrightSpringer Nature Switzerland AG 2020
The information of publication is updating

書(shū)目名稱Drug Delivery Challenges and Novel Therapeutic Approaches for Retinal Diseases影響因子(影響力)




書(shū)目名稱Drug Delivery Challenges and Novel Therapeutic Approaches for Retinal Diseases影響因子(影響力)學(xué)科排名




書(shū)目名稱Drug Delivery Challenges and Novel Therapeutic Approaches for Retinal Diseases網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱Drug Delivery Challenges and Novel Therapeutic Approaches for Retinal Diseases網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱Drug Delivery Challenges and Novel Therapeutic Approaches for Retinal Diseases被引頻次




書(shū)目名稱Drug Delivery Challenges and Novel Therapeutic Approaches for Retinal Diseases被引頻次學(xué)科排名




書(shū)目名稱Drug Delivery Challenges and Novel Therapeutic Approaches for Retinal Diseases年度引用




書(shū)目名稱Drug Delivery Challenges and Novel Therapeutic Approaches for Retinal Diseases年度引用學(xué)科排名




書(shū)目名稱Drug Delivery Challenges and Novel Therapeutic Approaches for Retinal Diseases讀者反饋




書(shū)目名稱Drug Delivery Challenges and Novel Therapeutic Approaches for Retinal Diseases讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics
 

0票 0%

Better Implies Difficulty
 

0票 0%

Good and Satisfactory
 

0票 0%

Adverse Performance
 

0票 0%

Disdainful Garbage
您所在的用戶組沒(méi)有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 22:25:34 | 只看該作者
978-3-030-56621-0Springer Nature Switzerland AG 2020
板凳
發(fā)表于 2025-3-22 03:24:27 | 只看該作者
地板
發(fā)表于 2025-3-22 05:47:49 | 只看該作者
5#
發(fā)表于 2025-3-22 09:52:00 | 只看該作者
6#
發(fā)表于 2025-3-22 14:04:51 | 只看該作者
https://doi.org/10.1007/978-3-662-36243-3o major clinical presentations of AMD: atrophic or “dry” and neovascular or “wet.” Geographic atrophy (GA) is the most severe manifestation of dry AMD which represents the form of the disease characterized by the highest prevalence. A smaller fraction of AMD patients (10–20%) develop choroidal neova
7#
發(fā)表于 2025-3-22 17:03:15 | 只看該作者
8#
發(fā)表于 2025-3-22 22:18:26 | 只看該作者
9#
發(fā)表于 2025-3-23 04:21:14 | 只看該作者
https://doi.org/10.1007/978-3-662-36243-3but the number of clinical gene therapy trials has been very limited. The improved visual function outcomes in individuals affected by retinal dystrophy caused by biallelic variants in the RPE65 gene after gene therapy treatment contributed to the US Food and Drug Administration (FDA) and European M
10#
發(fā)表于 2025-3-23 06:25:27 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-26 00:15
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
清徐县| 江阴市| 夏邑县| 内江市| 锦屏县| 沈丘县| 修文县| 铁力市| 荔浦县| 金华市| 张北县| 华容县| 交口县| 竹山县| 隆尧县| 长武县| 响水县| 隆安县| 绍兴县| 清流县| 会昌县| 夹江县| 宾阳县| 莒南县| 象州县| 阿克陶县| 泰州市| 宜川县| 阜城县| 阜南县| 益阳市| 华亭县| 凉山| 巩留县| 高平市| 栾城县| 五家渠市| 阿图什市| 天柱县| 利津县| 十堰市|